Variant report
Variant | esv3369976 |
---|---|
Chromosome Location | chr13:62469351-62474849 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553587381 | chr13:62470409-62470410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372403609 | chr13:62470419-62470420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571890030 | chr13:62470468-62470469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551731830 | chr13:62470498-62470499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189016204 | chr13:62470530-62470531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372659790 | chr13:62470579-62470580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375131509 | chr13:62470613-62470614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571280298 | chr13:62470661-62470662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143299296 | chr13:62470665-62470666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1953049 | chr13:62470705-62470706 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs566792815 | chr13:62470710-62470711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534208551 | chr13:62470730-62470731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77568091 | chr13:62470744-62470745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs530253510 | chr13:62470754-62470755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548377944 | chr13:62470794-62470795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560694629 | chr13:62470819-62470820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs151140739 | chr13:62470823-62470824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552915571 | chr13:62470833-62470834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371940814 | chr13:62470870-62470871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113944776 | chr13:62470891-62470892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181726307 | chr13:62470922-62470923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576770566 | chr13:62470952-62470953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150470624 | chr13:62470999-62471000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187425490 | chr13:62471062-62471063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs553425584 | chr13:62471064-62471065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145413075 | chr13:62471067-62471068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189132864 | chr13:62471073-62471074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567226404 | chr13:62471076-62471077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557630703 | chr13:62471084-62471085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17060543 | chr13:62471147-62471148 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs550229937 | chr13:62471180-62471181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76915914 | chr13:62471221-62471222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs574718227 | chr13:62471243-62471244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542364468 | chr13:62471246-62471247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373421488 | chr13:62471276-62471277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs57839613 | chr13:62471312-62471313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs3085378 | chr13:62471319-62471320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181074646 | chr13:62471348-62471349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538382277 | chr13:62471350-62471351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71439918 | chr13:62471381-62471382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs570100426 | chr13:62471382-62471383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9570630 | chr13:62471408-62471409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9317205 | chr13:62471421-62471422 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs550187827 | chr13:62471452-62471453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs9570631 | chr13:62471464-62471465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs574389384 | chr13:62471476-62471477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115717371 | chr13:62471509-62471510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146818344 | chr13:62471527-62471528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547097774 | chr13:62471582-62471583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs17205601 | chr13:62471617-62471618 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:62470400-62470800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr13:62470800-62474400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr13:62473000-62473200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr13:62473200-62474000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr13:62473400-62474200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr13:62473800-62474400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr13:62474000-62475800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr13:62474200-62474400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
9 | chr13:62474200-62475000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr13:62474200-62475000 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
11 | chr13:62474200-62475400 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr13:62474200-62475600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr13:62474200-62475800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr13:62474400-62474600 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
15 | chr13:62474400-62474800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr13:62474400-62475400 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
17 | chr13:62474600-62474800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr13:62474600-62475000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr13:62474600-62475600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr13:62474800-62475000 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |